The COLOPEC study established its primary endpoint as peritoneal disease-free survival at 18 months; this parameter failed to achieve significance between the two groups (18-month peritoneal-free survival in HIPEC group 80.9% vs 76.2% in control, p=0.280).
← all excerpts
Effect of HIPEC on Peritoneal Recurrence in Peritoneal Metastasis Treated With Cytoreductive Surgery: A Systematic Review.
1
0.2800
0.2800